Evidence map›Paper›PMID 33806050›Full record

ReviewInternational journal of molecular sciences2021

Berries and Their Polyphenols as a Potential Therapy for Coronary Microvascular Dysfunction: A Mini-Review.

Rami S Najjar, Arielle M Schwartz, Brett J Wong, Puja K Mehta, Rafaela G Feresin

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Prognostic value of myocardial flow reserve measured with CZT cardiac-dedicated SPECT low-dose dynamic myocardial perfusion imaging in patients with INOCA.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023
    Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Rami S NajjarDepartment of Nutrition, Georgia State University, Atlanta, GA 30302, USA.ORCID 0000-0001-5348-3008
Arielle M SchwartzJ. Willis Hurst Internal Medicine Residency Program, Emory University, Atlanta, GA 30322, USA.
Brett J WongDepartment of Kinesiology & Health, Georgia State University, Atlanta, GA 30302, USA.ORCID 0000-0002-4763-0208
Puja K MehtaDivision of Cardiology, Emory Women's Heart Center, Emory University School of Medicine, Atlanta, GA 30322, USA.
Rafaela G FeresinDepartment of Nutrition, Georgia State University, Atlanta, GA 30302, USA.ORCID 0000-0003-0649-2774
Georgia State University · USEmory University · US

Funding

NIH HHS 1U54AG062334-01U.S. Department of Agriculture 019-67017-29257
6 · The paper itself

Abstract

Ischemia with no obstructive coronary artery disease (INOCA) is a common diagnosis with a higher prevalence in women compared to men. Despite the absence of obstructive coronary artery disease and no structural heart disease, INOCA is associated with major adverse cardiovascular outcomes as well a significant contributor to angina and related disability. A major feature of INOCA is coronary microvascular dysfunction (CMD), which can be detected by non-invasive imaging and invasive coronary physiology assessments in humans. CMD is associated with epicardial endothelial-dependent and -independent dysfunction, diffuse atherosclerosis, and left-ventricular hypertrophy, all of which lead to insufficient blood flow to the myocardium. Inflammatory and oxidative stress signaling, upregulation of the renin-angiotensin-aldosterone system and adrenergic receptor signaling are major drivers of CMD. Treatment of CMD centers around addressing cardiovascular risk factors; however, there are limited treatment options for those who do not respond to traditional anti-anginal therapies. In this review, we highlight the ability of berry-derived polyphenols to modulate those pathways. The evidence supports the need for future clinical trials to investigate the effectiveness of berries and their polyphenols in the treatment of CMD in INOCA patients.

Indexed as

MicrocirculationAnimalsCoronary Artery DiseaseCoronary CirculationCoronary VesselsFruitHeart DiseasesHemodynamicsHumansInflammationMiceMyocardial IschemiaOxidative StressPolyphenolsRatsReceptors, AdrenergicPolyphenolsReceptors, Adrenergicadrenergicangiotensinberriesendothelial dysfunctioninflammationischemic heart diseasemicrovascularoxidative stresspolyphenols

Identifiers

PMID33806050
PMCPMC8036956
OpenAlexW3151903745

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.